March 2011, Volume 2, Issue 1, pp 33-41,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 04 Nov 2010
Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
We examined the neuroprotective efficacy of docosahexaenoic acid (DHA), an omega-3 essential fatty acid family member, in acute ischemic stroke; studied the therapeutic window; and investigated whether DHA administration after an ischemic stroke is able to salvage the penumbra. In each series described below, SD rats underwent 2 h of middle cerebral artery occlusion (MCAo). In series 1, DHA or saline was administered i.v. at 3, 4, 5, or 6 h after stroke. In series 2, MRI was conducted on days 1, 3 and 7. In series 3, DHA or saline was administered at 3 h, and lipidomic analysis was conducted on day 3. Treatment with DHA significantly improved behavior and reduced total infarct volume by a mean of 40% when administered at 3 h, by 66% at 4 h, and by 59% at 5 h. Total lesion volumes computed from T2-weighted images were reduced in the DHA group at all time points. Lipidomic analysis showed that DHA treatment potentiates neuroprotectin D1 (NPD1) synthesis in the penumbra 3 days after MCAo. DHA administration provides neurobehavioral recovery, reduces brain infarction and edema, and activates NPD1 synthesis in the penumbra when administered up to 5 h after focal cerebral ischemia in rats.
Bazan NG. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture. Investig Ophthalmol Vis Sci. 2007;48:4866–81.CrossRef
Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005;15:159–66.
Ward RE, Huang W, Curran OE, Priestly JV, Michael-Titus AT. Docosahexaenoic acid prevents white matter damage following spinal cord injury. J Neurotrauma. 2010;27:1–12.CrossRef
Belayev L, Alonso OF, Busto L, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke. 1996;27:1616–22.PubMed
Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674–88.CrossRef
Muralikrishna AR, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006;40:376–87.CrossRef
Hossmann KA, Traystman RJ. Chapter 4: cerebral blood flow and the ischemic penumbra. Handb Clin Neurol. 2008;92:67–92.CrossRef
Liu S, Levine SR, Winn HR. Targeting ischemic penumbra. Part 1. J Exp Stroke Transl Med. 2010;3:47–55.PubMed
- Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Translational Stroke Research
Volume 2, Issue 1 , pp 33-41
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Focal ischemia
- Magnetic resonance imaging
- Animal models
- Author Affiliations
- 1. Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, 2020 Gravier Street, Suite D, New Orleans, LA, 70112, USA
- 2. Non-Invasive Imaging Laboratory, Loma Linda University, Loma Linda, CA, USA